The OECD Health Care Quality Indicators Project

Similar documents
OECD S HEALTH AT A GLANCE 2015 WHAT INSIGHTS FOR THE UK? Mark Pearson, Deputy Director Directorate for Employment, Labour and Social Affairs

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

PROGRESS ON HCQI RESEARCH AND DEVELOPMENT WORK

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

CARDIOVASCULAR DISEASE AND DIABETES:

Johns Hopkins individualized Health Initiative

The health economic landscape of cancer in Europe

Request for Letters of Intent. International Development of H5N1 Influenza Vaccines

Allied Health: Sustainable Integrated Health Care for all Australians

NATIONAL COST OF OBESITY SEMINAR. Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

European Collaboration on Dementia. Luxembourg, 13 December 2006

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

HPV, Cancer and the Vaccination Programme

Case study examining the impact of German reunification on life expectancy

Cardiovascular Disease and Diabetes Policies for Better Health and Quality of Care

Alcohol Prevention Day

BioPlex 2200 Infectious Disease Panels

Methodological Issues

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Main developments in past 24 hours

MENTAL HEALTH DISORDERS: THE ECONOMIC CASE FOR ACTION Mark Pearson Head of Department, OECD Health Division

Financing the Response to HIV/AIDS in Low and Middle Income Countries: Funding for HIV/AIDS from the G7 and the European Commission


Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU

WCPT COUNTRY PROFILE December 2017 SWEDEN

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Prof. Dr. Gabor Ternak

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SERBIA

Introduction to Cost-Effectiveness Analysis

PyroMark Q24 CpG MGMT Handbook

The influence of societal individualism on a century of tobacco use: modelling the prevalence of smoking Appendices A and B

EUROHOPE: Hip fracture in Europe are slippery regions different?

Urgent Medical Device Correction

Deceased donation data in the UK. Paul Murphy National Clinical Lead for Organ Donation United Kingdom

European Experience and Perspective on Assessing Value for Oncology Products. Michael Drummond Centre for Health Economics, University of York

CNAPA Meeting Luxembourg September 2016

European Association for Cardiovascular Prevention & Rehabilitation (EACPR) A Registered Branch of the ESC

COMMISSION OF THE EUROPEAN COMMUNITIES

The contribution of. improved outcomes and economic growth. Frank Lichtenberg. Content

Authors: Jennifer Kates (Kaiser Family Foundation), José-Antonio Izazola (UNAIDS), Eric Lief (CSIS).

European Community Pharmacy: a reference in Public Health

Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.

EUVAC.NET A surveillance network for vaccine-preventable diseases

Smokefree Policies in Europe: Are we there yet?

Required Certificate of Immunization

The Urgency of the Situation: The Cost of Childhood Obesity for Society

Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).

LEBANON. WCPT COUNTRY PROFILE December 2018

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

Colorectal cancer. New Zealand s place in the world. Inequities in outcomes? Assoc Prof Diana Sarfati

OECD Family database OECD - Social Policy Division - Directorate of Employment, Labour and Social Affairs

Modelling diabetes Professor Alastair Gray Health Economics Research Centre University of Oxford

DENMARK. WCPT COUNTRY PROFILE December 2018

Key Highlights continued

Overview of drug-induced deaths in Europe - What does the data tell us?

Highly pathogenic avian influenza "The Epidemic" Regionalisation in the European Union

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011

PLACEMENT AND TREATMENT OF MENTALLY ILL OFFENDERS LEGISLATION AND PRACTICE IN EU-MEMBER STATES

Where do EU Contries set the limit for low risk drinking.

Monthly measles and rubella monitoring report

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

The first and only fully-automated, multiplexed solution for Measles, Mumps, Rubella and Varicella-zoster virus antibody testing

European Status report on Alcohol and Health

GERMANY. WCPT COUNTRY PROFILE December 2018

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link. Fully-Automated HbA 1c Testing

F. Lichtenberg, The contribution of pharmaceutical innovation to longevity growth in Germany and France, Pharmacoeconomics (In press)

UK bowel cancer care outcomes: A comparison with Europe

Bio-Rad Laboratories. Hemoglobin Testing. VARIANT II Hemoglobin Testing System For HbA 1c

Note on the harmonisation of SILC and EHIS questions on health

Analysis of access to innovative medicines in Chile compared to other OECD countries

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

Real Life, Real PD Survey

The Risk of Alcohol in Europe. Bridging the Gap June 2004

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

Palliative nursing care of children and young people across Europe

What can the NHS do to reduce premature mortality? Professor Sir Mike Richards NHS Health Check National Learning Event April 2013

The HeartQol questionnaire. Reliability, validity and responsiveness?

NobelProcera Implant Bar Overdenture complete range of fixed and removable solutions.

The Official Journal of the Kettil Bruun Society for Social and Epidemiological Research on Alcohol

Alcohol-related harm in Europe and the WHO policy response

World Connections Committee (WCC) Report

PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT

Engagement in language assessment / Regions of Europe

31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million

Professional International Study Management

Cost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,

Weekly Influenza Surveillance Report. Week 11

Health Care Providers:

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link System. Fully-Automated HbA 1c Testing

Transcription:

The OECD Health Care Quality Indicators Project Ed Kelley, Ph.D. Head, OECD Health Care Quality Indicators Project Health Systems Working Party Luxembourg - April 26, 2005 1

Broad aims of the OECD s HCQI Project To develop a set of key indicators of the quality of health care (including prevention) for strategic international comparisons Confining attention (provisionally) to indicators of the technical quality of health care (=effectiveness) NOT responsiveness (at this stage) NOT disparities/inequities (at this stage) To be population-based, representative of the main disease and risk groups To be targeted at around 50 key indicators 2

Proposed conceptual framework Effectiveness of Care Stages of disease Staying healthy Getting better Living with illness and disability Coping with the end of life Concepts of technical quality of healthcare Safety Effectiveness Adapted from the classification matrix proposed by the US Institute of Medicine 3

How, in principle, should quality of care be measured (1)? By developing mainly process and outcome indicators of health care Proposed criteria for selecting indicators Importance of what is being measured Impact of disease or risk on health and on health expenditure Policy importance Susceptibility to interventions Scientific soundness of the measure Validity Reliability Explicitness of evidence base 4

How, in principle, should quality of care be measured (2)? Proposed criteria for selecting indicators (continued) Feasibility of obtaining internationally comparable data Existence of prototypes Availability of data Cost of measurement/collection 5

HQCI Work To-Date Review of conceptual frameworks, and other HCQIs already in use in member countries. Preliminary Report on availability and comparability developed for 17 initial indicators. Expert panels convened to recommend indicators for 5 priority areas (see next) These reports have been released as Health Technical Papers (Numbers 14-18) [www.oecd.org/health] 6

Phase 1 Analysis of available measures, e.g.: HCQI Work to Date The Nordic Group Conceptual work, Indicator review Concepts of technical quality of healthcare Phase 2 Full report on broader measure set Safet y Effectiveness St ag es of dis eas e Staying healthy Getting better Living with illness and disability Coping with the end of life 7

Indicator Areas Preliminary Report/Phase 1 Cancer screening rates and survival Vaccination rates for children and elderly Mortality rates for asthma, heart attack and stroke Waiting times for surgery (hip fracture) Diabetes control and adverse outcome rates Smoking rates Phase 2 Phase 1 indicators, plus: Promotion, prevention and primary care Mental health care Patient safety Cardiac care (additional indicators) Diabetes care (additional indicators) 8

Preliminary Report: Overall data availability is good Ready for publication with minimal work Requiring additional work Currently inadequate data coverage 2. Mammography Screening Rate 3. Cervical Cancer Screening Rate 7. Coverage for basic vaccination program, age 2 11. Percentage Femur Fractures Operated within 48 Hours 16. Influenza Vaccination for Adults over 65 17. Smoking Rates 1. Breast Cancer 5- Year Survival 3. Cervical Cancer 5- Year Survival 5. Colorectal Cancer 5- Year Survival 6. Incidence of Vaccine Preventable diseases 8. Asthma Mortality per 100,000 age 5-39 9. AMI 30-day Inhospital Case-Fatality Rate 10. Stroke 30-day Inhospital Case-Fatality Rate 14. Retinal Exams in Diabetics 15. Major Amputation in Diabetics 12. Diabetic Patients Tested for HbA1c in last year 13. Diabetic Patients with Poor Glucose Control Australia?? Austria?? Canada T Denmark??? Finland France Germany??? Iceland Ireland Italy Japan Mexico Netherlands??? New Zealand Norway Portugal Spain Sweden???? Switzerland United Kingdom United States

.but full comparability is not always given Minor issues: age ranges, time periods Can be dealt with by appropriate footnotes Major issues that can be addressed: Age standardization, inclusion criteria Major issues that cannot be addressed in the short run: data sources, patient vs episode-based calculation, sampling 10

Future Work OECD HCQI Work Plan for 2005-06 Work plan approved by the project steering group in October 2004: 2005 Finalizing the Conceptual Framework and Preliminary Report on Phase 1 Measures Starting the process to collect readily available data in the 5 priority areas 2006 Completing collection of available data in 5 priority areas Work with member countries to examine existing data collection on key indicators to improve international data comparability 11

Contact Information Ed Kelley, Ph.D. edward.kelley@oecd.org +33-1-45-24-92-39 (phone) +33-1-45-24-90-98 (fax) 12

This paper was produced for a meeting organized by Health & Consumer Protection DG and represents the views of its author on the subject. These views have not been adopted or in any way approved by the Commission and should not be relied upon as a statement of the Commission's or Health & Consumer Protection DG's views. The European Commission does not guarantee the accuracy of the data included in this paper, nor does it accept responsibility for any use made thereof.